CAWM
GILD icon

Capital Advisors Wealth Management’s Gilead Sciences GILD Stock Holding History

Capital Advisors Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Buy
3,386
+147
+5% +$19.4K 0.05% 153
2026
Q1 		$451K Buy
3,239
+15
+0.5% +$2.1K 0.06% 139
2025
Q4 		$396K Buy
3,224
+15
+0.5% +$1.82K 0.05% 144
2025
Q3 		$356K Buy
3,209
+30
+0.9% +$3.41K 0.05% 151
2025
Q2 		$352K Buy
3,179
+17
+0.5% +$1.81K 0.06% 141
2025
Q1 		$354K Buy
3,162
+298
+10% +$30.7K 0.06% 126
2024
Q4 		$265K Buy
2,864
+320
+13% +$28.8K 0.05% 144
2024
Q3 		$213K Buy
+2,544
New +$194K 0.04% 161

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Advisors Wealth Management's GILD Position: Q2 2026 in Review

Capital Advisors Wealth Management increased its Gilead Sciences (GILD) stake by 4.5% in Q2 2026, buying an estimated $19.4K and bringing the position to 3,386 shares worth $428K. The position accounts for 0.05% of the portfolio, ranked #153.

Capital Advisors Wealth Management first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $451K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capital Advisors Wealth Management held 3,386 shares of Gilead Sciences worth $428K as of Q2 2026.
  • Capital Advisors Wealth Management bought 147 Gilead Sciences shares in Q2 2026, an estimated $19.4K.
  • Gilead Sciences made up 0.05% of Capital Advisors Wealth Management's portfolio in Q2 2026, its #153 holding.
  • Capital Advisors Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • Capital Advisors Wealth Management's Gilead Sciences position peaked at $451K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capital Advisors Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.